A5076710493- Prostate Cancer Treatment and Research
- Cancer Diagnosis and Treatment
- Prostate Cancer Diagnosis and Treatment
- Nutrition and Health in Aging
- Colorectal Cancer Treatments and Studies
- Cancer Genomics and Diagnostics
- Bladder and Urothelial Cancer Treatments
- Renal cell carcinoma treatment
- Cancer Immunotherapy and Biomarkers
- Colorectal and Anal Carcinomas
- Sarcoma Diagnosis and Treatment
- Cancer and Skin Lesions
- Economic and Financial Impacts of Cancer
- COVID-19 and healthcare impacts
- Hepatocellular Carcinoma Treatment and Prognosis
- Lung Cancer Treatments and Mutations
- Male Reproductive Health Studies
- Cutaneous lymphoproliferative disorders research
- Full-Duplex Wireless Communications
- Intestinal Malrotation and Obstruction Disorders
- Frailty in Older Adults
- Ferroptosis and cancer prognosis
- Medical Imaging and Pathology Studies
- Body Composition Measurement Techniques
- Hormonal and reproductive studies
CUF Porto Hospital
2025
Universidade Católica Portuguesa
2023-2025
Centro Hospitalar de Lisboa Central
2016-2023
Companhia União Fabril
2023
Cambridge University Hospitals NHS Foundation Trust
2023
Addenbrooke's Hospital
2023
National Health Service
2023
Ordem dos Médicos
2023
Hospital Santo António dos Capuchos
2017-2020
Hospital de Santo António
2017-2020
Background/Objectives: Sarcopenia is an emergent prognostic biomarker in clinical oncology. Albeit increasingly defined through skeletal muscle index (SMI) thresholding, literature cut-offs fail to discern heterogeneous baseline muscularity across populations. This study assesses the impact of using cohort-specific SMI thresholds a Portuguese metastatic non-small-cell lung cancer (mNSCLC) cohort. Methods: Retrospective including mNSCLC patients treated between January 2017 and December 2022....
Background/Objectives: Sarcopenia is an emergent prognostic biomarker in clinical oncology. Albeit increasingly defined through skeletal muscle index (SMI) thresholding, the literature cut-offs fail to discern heterogeneous baseline muscularity across populations. This study assesses impact of using cohort-specific SMI thresholds a Portuguese metastatic non-small-cell lung cancer (mNSCLC) cohort. Methods: Retrospective including mNSCLC patients treated between January 2017 and December 2022....
In a very simplistic way, the human body has an extremely complex system of cell division that determines growth new cells and death senescent cells. However, organism is not perfect sometimes fails. course interaction between genetic environmental factors, including nutritional oncological disease can arise. Of course, no food alone properties capable preventing tumor. recent years there been increase in number cases cancer. Malnutrition cancer patients consequence inflammatory cytokines...
The authors present the case of a woman in seventh decade life with medical history of: left nephrectomy for renal tuberculosis and non-Hodgkin's lymphoma treated chemotherapy (QT) radiotherapy. She presented 2-month non-tender, inguinal lymph node enlargement. Positron Emission Tomography (PET)-CT -scanshowed hypermetabolic retroperitoneal lymphadenopathies, no primary tumour. On second dermatological examination pink, 2 cm plaque on anterior knee was noted. histopathological analysis...
Fibrolamellar carcinoma is a rare variant of hepatocellular not associated with cirrhosis or viral hepatitis. Serum alpha-fetoprotein levels are usually normal; the histology well-differentiated tumor, and staging same as for carcinoma. We describe case female patient in her 4th decade life diagnosis fibrolamellar multimodal approach. The incidence this cancer its unusual clinical presentation justifies reporting highlights importance multidisciplinary teams treatment patients.O Carcinoma...
Since the identification of multiple therapeutic targets, as is case anaplastic lymphoma kinase (ALK) translocation, paradigm treating patients with non-small cell lung cancer (NSCLC) has improved. In order to guarantee possibility longer survival outcomes a better quality life we must invest in determination, suitable time, consensual biomarkers and availability best treatments our patients.We present caucasian male his fifth decade life, non-smoker, who highlights complex journey...
An 85-year-old patient was brought to the emergency department due progressive weight loss and bed confinement over a period of 6 months. After recollecting fully detailed medical history, describes growth gruelling mass on her right breast course 1 year,
Non-metastatic castration-resistant prostate cancer (nmCRPC) represents a challenging disease state in care. nmCRPC patients with high risk of progression to metastatic who are identified by prostate-specific antigen doubling time (PSADT) ≤10 months eligible for treatment the novel androgen receptor inhibitors (ARIs), shown delay and extend survival. However, is often unexploited clinical practice due lack standardization methodology tools used its identification. In this article, group...
The modern era has brought an appreciation that renal cell carcinoma (RCC) includes diverse subtypes derived from the various parts of nephron, each with its distinctive genetic basis and tumor biology.Carcinoma collecting ducts Bellini (CDC) is a rare subtype RCC, predictably poor prognosis.This represents less than 1% all kidney carcinomas.It derives presumably numerous chromosomal losses.It chief importance to differentiate CDC other types cancer.Typically, it characterized by firm,...
e15743 Background: NG is a standard 1 st line treatment for APC. Although recommended in 2 nd after FOLFIRINOX, there little evidence of its efficacy, tolerability and markers efficacy. Methods: We performed multicenter retrospective cohort study, including patients (pts) with APC from 5 centers Portugal treated FOLFIRINOX 01/2013-12/2016. collected demographic, clinicopathological characteristics data. used descriptive statistics, Kaplan-Meier methods Cox proportional hazards analysis....
Coronavirus disease 2019 (COVID-19), first recognized in Wuhan, China, was recently declared a global pandemic by the World Health Organization (WHO). Advanced age and comorbid disease, well-known characteristics solid tumor population, have been reported as risk factors for severe death. Cancer-related immunosuppression its treatments also seem to play an active role prognosis, response, clinical outcomes of these patients. The most effective combination therapy COVID-19 is still under...
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | 1479-6848 (online)
In recent years there has been an increase in the number of new cases cancer. Malnutrition cancer patients is a consequence inflammatory cytokines associated with cancer, metabolic alterations, and concomitant inadequate availability nutrients, due to anorexia caused by disease systemic treatments. Nutrition can guide both growth progress disorders their prevention treatment. Irrevocably, it indispensable pair diet physical activity, balance nutritional status prime healthy lifestyle. An...